TrialAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2019

Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKD.

Andrew S Allegretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.